By Dan Schell and Brad Trevenen
In the fall of 2012, we started our “Companies To Watch” section to showcase some of the smaller, entrepreneurial biotechs and pharmas that had received little or no press coverage to date. We only chose companies that developed their own products — not just a platform — and had an interesting story to tell with useful business lessons. So far, we’ve covered more than 50 companies in this section. This year we plan to periodically look back at some of those companies we have profiled and see where they are today.